Selected research
Industry Research
Pharmaceutical 3PL Service Industry Research Report 2026
Market perspective
The global Pharmaceutical 3PL Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical 3PL Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical 3PL Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical 3PL Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical 3PL Service include DHL, FedEx, UPS, Kuehne+Nagel, DB Schenker, CH Robinson, CEVA Logistics, Kerry Logistics and Agility, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical 3PL Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical 3PL Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical 3PL Service Market by Company
DHL
FedEx
UPS
Kuehne+Nagel
DB Schenker
CH Robinson
CEVA Logistics
Kerry Logistics
Agility
Expeditors International of Washington Inc.
SF Express
AmerisourceBergen Corporation
EMS
Jd.Com, Inc.
Pharmaceutical 3PL Service Segment by Type
Transportation Service
Warehousing and Storage Service
Value-added Services
Pharmaceutical 3PL Service Segment by Application
SMEs
Large Enterprise
Pharmaceutical 3PL Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical 3PL Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical 3PL Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical 3PL Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical 3PL Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transportation Service
- Warehousing and Storage Service
- Value-added Services
Applications
- SMEs
- Large Enterprise
Companies covered
- DHL
- FedEx
- UPS
- Kuehne+Nagel
- DB Schenker
- CH Robinson
- CEVA Logistics
- Kerry Logistics
- Agility
- Expeditors International of Washington Inc.
- SF Express
- AmerisourceBergen Corporation
- EMS
- Jd.Com, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical 3PL Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Transportation Service
- 2.2.3 Warehousing and Storage Service
- 2.2.4 Value-added Services
- 2.3 Pharmaceutical 3PL Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 SMEs
- 2.3.3 Large Enterprise
- 2.4 Assumptions and Limitations
3 Pharmaceutical 3PL Service Breakdown Data by Type
- 3.1 Global Pharmaceutical 3PL Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical 3PL Service Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical 3PL Service Breakdown Data by Application
- 4.1 Global Pharmaceutical 3PL Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical 3PL Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical 3PL Service Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical 3PL Service Growth Trends by Region
- 5.2.1 Global Pharmaceutical 3PL Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical 3PL Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical 3PL Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical 3PL Service Market Dynamics
- 5.3.1 Pharmaceutical 3PL Service Industry Trends
- 5.3.2 Pharmaceutical 3PL Service Market Drivers
- 5.3.3 Pharmaceutical 3PL Service Market Challenges
- 5.3.4 Pharmaceutical 3PL Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical 3PL Service Players by Revenue
- 6.1.1 Global Top Pharmaceutical 3PL Service Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical 3PL Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical 3PL Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical 3PL Service Head Office and Area Served
- 6.4 Global Pharmaceutical 3PL Service Players, Product Type & Application
- 6.5 Global Pharmaceutical 3PL Service Manufacturers Established Date
- 6.6 Global Pharmaceutical 3PL Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical 3PL Service Market Size (2021-2032)
- 7.2 North America Pharmaceutical 3PL Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical 3PL Service Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical 3PL Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical 3PL Service Market Size (2021-2032)
- 8.2 Europe Pharmaceutical 3PL Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical 3PL Service Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical 3PL Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical 3PL Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical 3PL Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical 3PL Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical 3PL Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical 3PL Service Market Size (2021-2032)
- 10.2 South America Pharmaceutical 3PL Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical 3PL Service Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical 3PL Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical 3PL Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical 3PL Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical 3PL Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical 3PL Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 DHL
- 12.1.1 DHL Company Information
- 12.1.2 DHL Business Overview
- 12.1.3 DHL Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.1.4 DHL Pharmaceutical 3PL Service Product Portfolio
- 12.1.5 DHL Recent Developments
- 12.2 FedEx
- 12.2.1 FedEx Company Information
- 12.2.2 FedEx Business Overview
- 12.2.3 FedEx Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.2.4 FedEx Pharmaceutical 3PL Service Product Portfolio
- 12.2.5 FedEx Recent Developments
- 12.3 UPS
- 12.3.1 UPS Company Information
- 12.3.2 UPS Business Overview
- 12.3.3 UPS Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.3.4 UPS Pharmaceutical 3PL Service Product Portfolio
- 12.3.5 UPS Recent Developments
- 12.4 Kuehne+Nagel
- 12.4.1 Kuehne+Nagel Company Information
- 12.4.2 Kuehne+Nagel Business Overview
- 12.4.3 Kuehne+Nagel Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.4.4 Kuehne+Nagel Pharmaceutical 3PL Service Product Portfolio
- 12.4.5 Kuehne+Nagel Recent Developments
- 12.5 DB Schenker
- 12.5.1 DB Schenker Company Information
- 12.5.2 DB Schenker Business Overview
- 12.5.3 DB Schenker Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.5.4 DB Schenker Pharmaceutical 3PL Service Product Portfolio
- 12.5.5 DB Schenker Recent Developments
- 12.6 CH Robinson
- 12.6.1 CH Robinson Company Information
- 12.6.2 CH Robinson Business Overview
- 12.6.3 CH Robinson Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.6.4 CH Robinson Pharmaceutical 3PL Service Product Portfolio
- 12.6.5 CH Robinson Recent Developments
- 12.7 CEVA Logistics
- 12.7.1 CEVA Logistics Company Information
- 12.7.2 CEVA Logistics Business Overview
- 12.7.3 CEVA Logistics Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.7.4 CEVA Logistics Pharmaceutical 3PL Service Product Portfolio
- 12.7.5 CEVA Logistics Recent Developments
- 12.8 Kerry Logistics
- 12.8.1 Kerry Logistics Company Information
- 12.8.2 Kerry Logistics Business Overview
- 12.8.3 Kerry Logistics Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.8.4 Kerry Logistics Pharmaceutical 3PL Service Product Portfolio
- 12.8.5 Kerry Logistics Recent Developments
- 12.9 Agility
- 12.9.1 Agility Company Information
- 12.9.2 Agility Business Overview
- 12.9.3 Agility Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.9.4 Agility Pharmaceutical 3PL Service Product Portfolio
- 12.9.5 Agility Recent Developments
- 12.10 Expeditors International of Washington Inc.
- 12.10.1 Expeditors International of Washington Inc. Company Information
- 12.10.2 Expeditors International of Washington Inc. Business Overview
- 12.10.3 Expeditors International of Washington Inc. Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.10.4 Expeditors International of Washington Inc. Pharmaceutical 3PL Service Product Portfolio
- 12.10.5 Expeditors International of Washington Inc. Recent Developments
- 12.11 SF Express
- 12.11.1 SF Express Company Information
- 12.11.2 SF Express Business Overview
- 12.11.3 SF Express Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.11.4 SF Express Pharmaceutical 3PL Service Product Portfolio
- 12.11.5 SF Express Recent Developments
- 12.12 AmerisourceBergen Corporation
- 12.12.1 AmerisourceBergen Corporation Company Information
- 12.12.2 AmerisourceBergen Corporation Business Overview
- 12.12.3 AmerisourceBergen Corporation Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.12.4 AmerisourceBergen Corporation Pharmaceutical 3PL Service Product Portfolio
- 12.12.5 AmerisourceBergen Corporation Recent Developments
- 12.13 EMS
- 12.13.1 EMS Company Information
- 12.13.2 EMS Business Overview
- 12.13.3 EMS Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.13.4 EMS Pharmaceutical 3PL Service Product Portfolio
- 12.13.5 EMS Recent Developments
- 12.14 Jd.Com, Inc.
- 12.14.1 Jd.Com, Inc. Company Information
- 12.14.2 Jd.Com, Inc. Business Overview
- 12.14.3 Jd.Com, Inc. Revenue in Pharmaceutical 3PL Service Business (2021-2026)
- 12.14.4 Jd.Com, Inc. Pharmaceutical 3PL Service Product Portfolio
- 12.14.5 Jd.Com, Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst